OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins in hospitalized COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
Yajuan Ren, Guizuo Wang, Dong Han
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 15

Showing 15 citing articles:

Simvastatin in Critically Ill Patients with Covid-19
Thomas Hills, Elizabeth Lorenzi, Lindsay R. Berry, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 25, pp. 2341-2354
Open Access | Times Cited: 32

Adjunctive Statin Therapy in Patients with Covid-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cynthia Florêncio de Mesquita, André Rivera, Beatriz Araújo, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 10, pp. 966-973.e11
Closed Access | Times Cited: 4

Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jinlv Qin, Guizuo Wang, Dong Han
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 931-937
Closed Access | Times Cited: 3

Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 2

The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2
Simona Fenizia, Melania Gaggini, Cristina Vassalle
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7956-7973
Open Access | Times Cited: 5

Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on In-Hospital Mortality of COVID-19 Patients
Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Majid Haji Maghsoudi
Journal of Pharmaceutical Care (2024)
Open Access | Times Cited: 1

Biomarkers, Pandemics and Host Response Treatment
David S. Fedson
Journal of Nursing & Healthcare (2024) Vol. 9, Iss. 2, pp. 01-15
Open Access

Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors
Koushik Reddy, Kamil F. Faridi, Monica Aggarwal, et al.
American Journal of Lifestyle Medicine (2024)
Closed Access

Statins for the treatment of COVID-19 patients: an updated meta-analysis of randomized controlled trials
Fatemeh Movahed, Ehsan Heidari, Masoud Dehbozorgi, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access

Klotho Deficiency in Severe COVID-19: A Unifying Hypothesis
Natalia Campos‐Obando, M. Carola Zillikens, Román F. Macaya
COVID (2024) Vol. 4, Iss. 12, pp. 1833-1850
Open Access

Visceral fat as the main tomographic risk factor for COVID-19 mortality
Luis Ricardo Hinojosa-Gutiérrez, Antonio González, Jair Antonio Rios-Muñoz, et al.
Heart & Lung (2024) Vol. 70, pp. 191-196
Closed Access

Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
Javier Mancilla-Galindo, Ashuin Kammar‐García, María de Lourdes Mendoza-Gertrudis, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1

Page 1

Scroll to top